Events are FREE to qualified industry participants and decision-makers.

Evaluating Biopharma Events
Evaluating Biopharma Events
  • Home
  • Upcoming Events
    • Supply Chain Challenges
    • Process Intensification
    • Cell Therapy Strategies
    • Event Floorplan & Agenda
  • On Demand
    • On Demand Pharma
    • On Demand Tech
    • On Demand Operations
    • On Demand Continuous
  • Sponsorship
    • Sponsorship
    • Premier Sponsors
  • About Us
    • Evaluate Biopharma
  • More
    • Home
    • Upcoming Events
      • Supply Chain Challenges
      • Process Intensification
      • Cell Therapy Strategies
      • Event Floorplan & Agenda
    • On Demand
      • On Demand Pharma
      • On Demand Tech
      • On Demand Operations
      • On Demand Continuous
    • Sponsorship
      • Sponsorship
      • Premier Sponsors
    • About Us
      • Evaluate Biopharma
  • Sign In
  • Create Account
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Upcoming Events
  • On Demand
  • Sponsorship
  • About Us

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

Registration Open! - Continuous Bioprocessing – Justifying Your Company’s Investment, June 16, 2022

Register Now!

TECHNOLOGY’S EVOLUTION & IMPACT ON MANUFACTURING

Technology's Evolution & Impact on Manufacturing Opening Remarks

Implementation of a Continuous Technology Strategy to Support Therapeutic Protein Production

Jean-Marc Bielser (process technologies innovation, Merck Serono SA, an affiliate of Merck KGaA, Darmstadt, Germany) and moderator Ben Locwin (executive, Black Diamond Networks) discuss how MerckSerono SA implemented the change to CM to address future biomanufacturing challenges.

Read Summary Article

CGT Build or Buy Decision: A Complex Decision for CGT Companies That Use and Must be Experts in Multiple Technologies

Dave Backer (Dave Backer, chief commercial officer, Oxford Biomedica) and Ben Locwin (executive, Black Diamond Networks) discuss the difficult and complex business and technology decisions cell and gene therapy must correctly make to accelerate efficiency and speed to market.

Read Summary Article

Addressing Technology Challenges to Support Continuous Manufacturing at GMP

 Morten Munk (director – global alliance management, FUJIFILM Diosynth Biotechnologies) and Ben Locwin (executive, Black Diamond Networks) discuss his CM experience and how biopharmaceutical companies should approach moving from theoretical to actual implementation.

No Summary Article

Scale-Up Challenges of E. coli Protein Production Process

Parrish Galliher (independent bioprocess consultant) and moderator Ben Locwin (executive, Black Diamond Networks) discuss how he identified the cause and resolved one biopharma company's situation where protein production at scale produced the wrong sequence and changed the protein.

Read Summary Article

Increased Bioburden Excursion in an Aging Facility

Ron Bates (vice president, development and manufacturing, Immunovant) and Ben Locwin (executive, Black Diamond Networks) discuss the options biopharma companies operating older facilities can implement to reduce the number of environmental hits.

Read Summary Article

Implementing Process Intensification to Support ATMP Market Demands

William Whitford (life sciences strategic solutions leader, DPS Group) and moderator Ben Locwin (executive Black Diamond Networks) discuss the current and next-gen technologies necessary to support ATMP process intensification.

Copyright © 2022 Evaluating Biopharma Events - All Rights Reserved.

Powered by GoDaddy Website Builder

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept